Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1248541-63-0 | MDL No. : | MFCD20037660 |
Formula : | C8H9BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GBHLKSOAANWXOZ-UHFFFAOYSA-N |
M.W : | 245.07 | Pubchem ID : | 58073920 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 54.23 |
TPSA : | 78.34 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.62 cm/s |
Log Po/w (iLOGP) : | 1.52 |
Log Po/w (XLOGP3) : | 1.66 |
Log Po/w (WLOGP) : | 1.42 |
Log Po/w (MLOGP) : | 1.48 |
Log Po/w (SILICOS-IT) : | 0.95 |
Consensus Log Po/w : | 1.41 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.61 |
Solubility : | 0.595 mg/ml ; 0.00243 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.92 |
Solubility : | 0.295 mg/ml ; 0.00121 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.61 |
Solubility : | 0.596 mg/ml ; 0.00243 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With iron; ammonium chloride In tetrahydrofuran; ethanol; water at 95℃; for 1 h; | Methyl 2-amino-5-bromo-3-nitrobenzoate (0.67 g, 2.44 mmol), iron (0.68 g, 12.0 mmol), and ammonium chloride (1.96 g, 37.0 mmol) were dissolved in a 1:1:0.4 mixture of THF/ethanol/water (29 mL) and heated at 95° C. with vigorous stirring for 1 hour. The reaction mixture was cooled to room temperature and filtered through a plug of Celite to remove solids. The plug was rinsed repeatedly with methanol and tetrahydrofuran. The filterate was concentrated and the residue partitioned between ethyl acetate and water. The organic later was washed once with brine and concentrated to give methyl 2,3-diamino-5-bromobenzoate (0.59 g, 99percent) as a yellow powder which was used without further purification |
89.1% | for 4 h; Reflux | Roundbottom flask equipped with reflux condenser is charged with methyl 2- amino-5-bromo-3-nitrobenzoate (Intermediate 165) (0.86 g; 3.02 mmol; 1.00 eg.), iron (1 .01 g; 18.13 mmol; 6.00 eg.) and ammonium chloride (1 .62 g; 30.22 mmol; 10.00 eq?.). Resulted slurry is stirred and refluxed for 4 h, then cooled down to room temperature, diluted with EtOAc and phased by pad of celite. Filtrate Is extracred subsequently with water, and brine. Organic layer id dried over Na2S04 and evaporated to give methyl 2,3-diamino- 5- bromobenzoate (0.71 g; 2.69 mmol; yield 89.1 percent; 93percent by UPLC) as brown solid which was used in next step without further purification. |
85.4% | With ammonium chloride; zinc In tetrahydrofuran; water at 20℃; for 1 h; | To a stirred solution of 2-amino-5-bromo-3-nitro-benzoic acid methyl ester (5.0 g, 18.2 mmol) in THF/Water (300/100 mL) was added zinc dust (8.12 g, 12.5 mmol) followed by ammonium chloride (13.25 g, 25.0 mmol) at room temperature. Then the reaction mixture allowed to stir at room temperature for lh. The progress of the reaction was monitored by TLC. The reaction mixture was filtered through celite and separated both the layers. The aqueous layer was extracted with ethyl acetate. The combined organic layer was dried over sodium sulphate and concentrated under reduced pressure to get the title compound as an ash colored solid (3.8 g, 85.4percent). ‘H NMR (300 MHz, DMSO-d6): ö 7.2 (s, 1H), 6.9 (s, 1H), 6.4 (bs, 2H), 5.2 (bs, 2H), 3.9 (s, 3H). |
[ 135484-83-2 ]
Methyl 2-amino-4-bromobenzoate
Similarity: 0.95
[ 52727-57-8 ]
Methyl 2-amino-5-bromobenzoate
Similarity: 0.95
[ 223519-11-7 ]
Methyl 3-amino-5-bromo-4-methylbenzoate
Similarity: 0.94
[ 206548-14-3 ]
Methyl 2-amino-5-bromo-3-methylbenzoate
Similarity: 0.92
[ 135484-83-2 ]
Methyl 2-amino-4-bromobenzoate
Similarity: 0.95
[ 52727-57-8 ]
Methyl 2-amino-5-bromobenzoate
Similarity: 0.95
[ 223519-11-7 ]
Methyl 3-amino-5-bromo-4-methylbenzoate
Similarity: 0.94
[ 206548-14-3 ]
Methyl 2-amino-5-bromo-3-methylbenzoate
Similarity: 0.92
[ 135484-83-2 ]
Methyl 2-amino-4-bromobenzoate
Similarity: 0.95
[ 52727-57-8 ]
Methyl 2-amino-5-bromobenzoate
Similarity: 0.95
[ 223519-11-7 ]
Methyl 3-amino-5-bromo-4-methylbenzoate
Similarity: 0.94
[ 206548-14-3 ]
Methyl 2-amino-5-bromo-3-methylbenzoate
Similarity: 0.92
[ 135484-83-2 ]
Methyl 2-amino-4-bromobenzoate
Similarity: 0.95
[ 52727-57-8 ]
Methyl 2-amino-5-bromobenzoate
Similarity: 0.95
[ 223519-11-7 ]
Methyl 3-amino-5-bromo-4-methylbenzoate
Similarity: 0.94
[ 206548-14-3 ]
Methyl 2-amino-5-bromo-3-methylbenzoate
Similarity: 0.92